These data indicate that COPD patients have lower survival despite similar levels of lung and blood SARS-CoV-2 viral load, which is associated with an upregulated inflammatory response involving increased numbers of memory T lymphocytes, mainly CD4+, but downregulation of genes associated with antigen-dependent T lymphocyte differentiation. This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.